An immunotherapy treatment that utilizes T cells to fight cancer may soon be covered by Medicare for mesothelioma patients. Immunotherapy is still an emerging set of cancer treatments that utilizes the patient’s own immune system to fight and kill cancer cells. The specific treatment that uses T cells is called chimeric antigen receptor (CAR) T-cell
Archive for the 'Overall Survival' Category
It was found that the number of pleural mesothelioma diagnoses has stayed the same, while the survival rate for people with the disease has slightly improved. Once asbestos was not used as much because of multiple regulations, the number of diagnoses of mesothelioma was predicted to go down. Instead, the number of diagnoses has remained
According to a study done at The University of Texas at Dallas, the Ketogenic diet, which is very low in sugar, as well as the administration of a diabetes drug that prevents glucose in the blood from being adsorbed by the kidneys, slowed down the growth of squamous cell carcinoma tumors in mice. This specific
The immune system is the body’s first line of defense when fighting off any illness, attacking foreign organisms or other substances that may harm or threaten the over health of the body. When the immune system is compromised, the body is unable to fight infections and becomes weak as the illness takes over. For those
Avastin (bevacizumab) is a type of chemotherapy treatment that slows tumor growth by blocking the protein that is responsible for forming new blood vessels, which is what tumors need to thrive. By blocking these blood vessels, tumor growth is slowed. For those suffering from mesothelioma, hindering tumor growth can greatly improve the quality of life
Pleural mesothelioma, caused by exposure to asbestos is a rare cancer – only 3,000 cases are diagnosed in the U.S. each year – but it is highly aggressive. There is no cure for plural mesothelioma but findings published in the Journal of Thoracic and Cardiovascular Surgery reveal that a new type of combination treatment specifically
A mesothelioma diagnosis can be grim and have life-long impact on the patients and family. The aggressive nature and the late diagnosis of the disease make it difficult to treat. The average life expectancy after initial diagnosis is on average one year, but with treatment – especially multimodality treatments – patients can live much longer.
In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes became a reality as the
When it comes to effective mesothelioma treatments, options are unfortunately limited. There is no cure for mesothelioma and first line chemotherapy treatment Alimta, is no guarantee. Many who are suffering from mesothelioma, who have found little or no comfort in traditional treatments, may turn to clinical trials for hope. Through clinical trials, patients have access
Radiotherapy, also known as radiation therapy, is a type of cancer treatment that uses ionizing radiation to kill cancer cells by damaging the cell’s DNA. It can be used as either a curative or palliative treatment and is often used alongside chemotherapy, either before, during, or after. Radiotherapy can be especially successful in some cancer
According to GLOBOCAN 2018 statistics, each year there are 30,443 mesothelioma cases worldwide, and of those 30,443, 25,576 pass away. With close to 85 percent of those diagnosed succumbing to the disease, mesothelioma remains one of the most deadly cancers as there is no cure. However, surviving a mesothelioma diagnosis is not entirely impossible as
A Phase III clinical trial is now underway in the pivotal study of interferon alfa-2b gene therapy in pleural mesothelioma. After promising results from the Phase II clinical trial, scientists and researchers are hopeful they are just one step away from FDA approval for this cancer treatment that is over 20 years in the making.
Predicting pleural mesothelioma survival is a difficult task, as a number of factors are needed to make an accurate calculation. Currently, the TNM Staging system in place as one of the ways to predict life-expectancy and survival after a mesothelioma patient has had surgery. However, researchers from Peking University in China have recently discovered what
Surgical techniques for those suffering from mesothelioma depend on how far the cancer has spread and if the patient is healthy enough to withstand such an invasive procedure. In many cases, the cancer has already spread too far and quickly, so surgery is not an option. For those able to treat their cancer with surgery,
Correcting genes that allow cancerous tumors to grow is the basis behind gene therapy, a relatively new treatment that is largely in experimental stages. The initial goals of gene therapy were to address hereditary genetic disorders, but other factors such as the sun, smoking, chemical exposure, etc., can all damage and change our DNA and
Last update: April 01, 2019. 03:30:08 pm.